Markets:

Overview

News

Currencies

International

Treasuries

Janux Therapeutics, Inc. - Common Stock (NQ:JANX)

35.11 +0.37 (+1.07%)

Streaming Delayed Price Updated: 11:36 AM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Janux Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Janux Therapeutics Promotes Co-Founder Tommy DiRaimondo, Ph.D. to Chief Scientific Officer

January 08, 2024

From Janux Therapeutics

Via Business Wire

Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

November 14, 2023

Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.

Via Benzinga

Janux Therapeutics: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

Janux Therapeutics's Return On Capital Employed Overview ↗

December 22, 2022

Via Benzinga

Why Janux Therapeutics Shares Rose 33.1% This Week ↗

October 22, 2022

The clinical-stage biotech company just began its first clinical trial.

Via The Motley Fool

Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday ↗

November 14, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter...

Via Benzinga

Topics Stocks

$27.5M Bet On Block? Check Out These 3 Stocks Insiders Are Buying ↗

November 14, 2023

Although U.S. stocks closed mixed on Monday, there were a few notable insider trades.

Via Benzinga

Janux Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights

November 07, 2023

From Janux Therapeutics

Via Business Wire

Janux Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights

August 08, 2023

From Janux Therapeutics

Via Business Wire

Becton, Dickinson and Company, Applied Digital, POSCO And Other Big Stocks Moving Higher On Monday ↗

July 24, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Janux Therapeutics' Stock Is Currently Undervalued, Analyst Highlights Prostate Cancer Candidate Potential ↗

July 17, 2023

Janux Therapeutics Inc (NASDAQ: JANX) announced interim Phase 1 clinical data for PSMA-TRACTr JANX007 in adult subjects with metastatic castration-

Via Benzinga

Janux Therapeutics Announces Pricing of $60 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

July 17, 2023

From Janux Therapeutics

Via Business Wire

Janux Therapeutics Announces Positive Interim Clinical Data from Phase 1a Dose Escalation for PSMA-TRACTr JANX007 and an Update on Pipeline Programs

July 17, 2023

From Janux Therapeutics, Inc.

Via Business Wire

Janux Therapeutics Appoints Zachariah McIver, D.O., Ph.D., Vice President, Clinical Development

June 05, 2023

From Janux Therapeutics

Via Business Wire

Janux Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights

May 09, 2023

From Janux Therapeutics

Via Business Wire

Janux Therapeutics to Participate at Upcoming May 2023 Investor Conferences

April 24, 2023

From Janux Therapeutics

Via Business Wire

Janux Therapeutics Announces First Patient Dosed with JANX008 in First-in-Human Phase 1 Clinical Trial in Patients with Solid Tumors

April 20, 2023

From Janux Therapeutics

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2023 ↗

April 06, 2023

Via Benzinga

7 Biotech Stocks That Could Be the Next Big Thing ↗

March 15, 2023

Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough.

Via InvestorPlace

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗

March 15, 2023

To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.

Via InvestorPlace

Janux Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights

March 10, 2023

From Janux Therapeutics

Via Business Wire

Janux Therapeutics to Participate in Novel IO Panel Discussion at Cowen's 43rd Annual Health Care Conference

February 14, 2023

From Janux Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 09, 2023

Via Benzinga

Why WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 01, 2023

Gainers Versus Systems Inc. (NASDAQ: VS) surged 270% to $2.26 after the company announced it will partner with Resolve to bring generative AI and gamification to customer payments and credit...

Via Benzinga

Janux Therapeutics Announces Submission of Investigational New Drug Application for JANX008, an EGFR-TRACTr for Solid Tumors

December 27, 2022

From Janux Therapeutics, Inc.

Via Business Wire

Janux Therapeutics to Present at Upcoming Investor Conferences in November

November 22, 2022

From Janux Therapeutics, Inc.

Via Business Wire

7 Short-Squeeze Stocks for Bold Contrarians to Consider ↗

November 21, 2022

While market volatility has brough the bears out of hibernation, certain short-squeeze stocks could be a trap for the pessimists.

Via InvestorPlace

Janux Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights

November 10, 2022

From Janux Therapeutics, Inc.

Via Business Wire

Janux Therapeutics Announces First Patient Dosed with JANX007 in First-in-Human Phase 1 Clinical Trial in Patients with Prostate Cancer

October 12, 2022

From Janux Therapeutics, Inc.

Via Business Wire

7 Short-Squeeze Stocks to Buy for Contrarian Investors ↗

October 12, 2022

The pessimists may have bitten off more than they can chew for these intriguing contrarian market ideas.

Via InvestorPlace

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.